Ovarian cancer cells use the contractility of integrin and actinomycin to exert force on fibronectin in the mesothelial monolayer, achieving gaps between mesothelial cells by retracting these cells, a phenomenon known as this mesothelial clearance [31]. Here, FN1 is linked to ovarian cancer.